MedTrace Logo

Serum CTRP3 and RBP4 Levels in Obesity and Hypertension

NCT02226471 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2014-08-27

No results posted yet for this study

Summary

Insulin resistance is closely correlated with obesity and cardiovascular disease. Adipokines may play important roles in the pathogenesis of obesity, which are a link between obesity and obesity-related disorders.C1q/TNF-related protein-3 (CTRP3) and retinol-binding protein 4 (RBP4) are novel adipokine that modulates the action of insulin in various diseases. This study addressed the relationship between CTRP3, RBP4 and IR in newly diagnosed obesity and essential hypertension.

Conditions

Sponsors & Collaborators

  • Third Military Medical University

    lead OTHER

Principal Investigators

  • Deng Wuquan, PHD · Southwest Hospital, China

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2014-02-28
Completion
2014-02-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02226471 on ClinicalTrials.gov